Advisory Services Network’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Advisory Services Network's ALNY Position: Q2 2026 in Review
Advisory Services Network increased its Alnylam Pharmaceuticals (ALNY) stake by 0.67% in Q2 2026, buying an estimated $12.7K and bringing the position to 6,356 shares worth $1.91M. The position accounts for 0.02% of the portfolio, ranked #720.
Advisory Services Network first reported a position in ALNY in Q3 2015 and has held it in 20 quarters since. The position peaked at $3.65M in Q1 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Advisory Services Network held 6,356 shares of Alnylam Pharmaceuticals worth $1.91M as of Q2 2026.
- Advisory Services Network bought 42 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $12.7K.
- Alnylam Pharmaceuticals made up 0.02% of Advisory Services Network's portfolio in Q2 2026, its #720 holding.
- Advisory Services Network first reported a position in Alnylam Pharmaceuticals in Q3 2015 and has held it in 20 quarters since.
- Advisory Services Network's Alnylam Pharmaceuticals position peaked at $3.65M in Q1 2025.
- 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.